We observed highly significant correlations between STK38L and KRAS expression levels in PDAC cell lines as well as primary tumors.
← all excerpts
STK38L kinase ablation promotes loss of cell viability in a subset of KRAS-dependent pancreatic cancer cell lines.
1
—
—